Loading…
A simple and sensitive LC-MS/MS method for therapeutic drug monitoring of digoxin in children
•The present method involves a simple protein precipitation procedure with good sensitivity.•Rapid chromatographic separation was achieved within 2.4 min based on a short EVO C18 column•LLOQ of 0.02 ng/mL based on 30 μL of plasma was obtained. This short communication introduced a simple and sensiti...
Saved in:
Published in: | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2023-04, Vol.1221, p.123681-123681, Article 123681 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | •The present method involves a simple protein precipitation procedure with good sensitivity.•Rapid chromatographic separation was achieved within 2.4 min based on a short EVO C18 column•LLOQ of 0.02 ng/mL based on 30 μL of plasma was obtained.
This short communication introduced a simple and sensitive LC-MS/MS method for therapeutic drug monitoring of digoxin in children with the lower limit of quantitation of 0.2 ng/mL based on 30 μL of plasma. The plasma sample was pretreated by one-step protein precipitation. Then the chromatographic separation was performed on a short C-18 column with a total run time of 2.4 min. The detection was achieved through multiple reaction monitoring using positive ionization mode on a triple quadrupole mass spectrometer. The linear range of digoxin in human plasma was among 0.2–6.4 ng/mL. The intra-day and inter-day accuracies of digoxin ranged from –6.0 % to 10.1 % and imprecisions were less than 8.8 %. The extraction recovery rate of digoxin in plasma samples was above 90 %. Matrix factor normalized by internal standard was within acceptance criteria. This method was fully verified and applied to determine the plasma digoxin concentrations of 43 pediatric patients. It is approved appropriate and practical for the therapeutic drug monitoring of digoxin in routine clinical laboratory practice, especially for children. |
---|---|
ISSN: | 1570-0232 1873-376X |
DOI: | 10.1016/j.jchromb.2023.123681 |